Skip to content
About
Our Agenda
Policy Issues
Policy Issues

We believe that patients should have access to innovative medicines.

Learn More
Innovation Ecosystem
Intellectual Property
Research & Development
Innovative Medicines
Government Price Setting
International
Patient Access & Affordability
PBMs & Middlemen
Hospitals and 340B
Insurance Coverage
Cost of Medicines
Medicare & Medicaid
Resources
Resources

Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies.

Learn More
Blog
Newsroom
Sites
PhRMA Sites
MAT
America's Medicines
PhRMA Foundation
Voters for Cures
Working for Cures
This is Innovation
Login
Building a
Better Health
Care System

We’re working to drive patient-centered progress in innovation, affordability and access to life saving prescription medicines.

Search in PhRMA

Find resources, news, and articles related to policy issues and scientific innovation. 

Blog
Historic biopharmaceutical investments: A prescription for America’s future

President Trump has called on U.S. industries to put America first, and the biopharmaceutical sector is answering that call with major actions to demonstrate our commitment to American patients and workers. 

Read More
Blog
Middlemen mark up drug prices and keep discounts meant for you

There’s growing recognition that middlemen, like PBMs and 340B hospitals, mark up medicines, leaving patients paying more. In fact, America is the only country in the world where half of every dollar spent on brand medicines goes to entities that don’t make them.

Read more
Landing Page
New "Mental Health" landing page

Biopharmaceutical innovation for mental health treatments has helped millions of Americans live healthier, more productive lives. Researchers are pursuing novel strategies to help bring new medicines to patients. It is vital to recognize that mental illness can be a serious disease and ensure Americans have access to life-saving care.

Learn More
Landing Page
2025 PhRMA Policy Agenda

The United States leads the world in biopharmaceutical innovation. Unfortunately, our inefficient system is costing Americans more than it should and limiting our ability to focus on keeping people healthy. Price setting creates more bureaucracy and threatens future cures without helping most patients. We need to defend American leadership – preserving jobs, access to cures and future innovation.

Learn More
Innovation Ecosystem

The innovation ecosystem drives scientific advances transforming how we fight disease with life-changing medicines and vaccines.

Innovation Ecosystem
Intellectual Property
Research & Development
Innovative Medicines
Government Price Setting
International
Patient Access & Affordability

Breakthrough science is transforming patient care. We have a commitment to not just develop treatments and cures, but to also help patients access them.

Patient Access & Affordability
PBMs and Middlemen
Hospitals and 340B
Insurance Coverage
Cost of Medicines
Medicare and Medicaid
Stay current on policy making

Sign up for email updates and follow us on social. 

Sign Up for Email Updates
About
Our Agenda
Policy Issues
Resources
Contact Us
Privacy Policy
Terms of Service

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review "1. Information Collection."

Pharmaceutical Research and Manufacturers of America® | 670 Maine Avenue, SW, Suite 1000, Washington, DC 20024